phone: +48 22 721 40 00   /  fax: +48 22 721 13 33  /   bioinfo@bioton.pl



Bioton



Current reports

 

Current report (26/2019) dated 03.10.2019, time. 16:45 UTC

Warsaw, 3 October 2019

Convening the Extraordinary General Meeting of Shareholders.

read more 


Current report (25/2019) dated 25.09.2019, time 12:19 UTC

Warsaw, 25 September 2019

Information on preliminary estimates of financial results made in the course of work on the periodic report.

read more 


Current report (24/2019) dated 07.09.2019, time 12:27 UTC

Warsaw, 7 September 2019

Termination of the agreement for the commercialization of recombinant human insulin in the territory of Brazil.

read more 


© 2019 BIOTON S.A.